In this study, we confirm a similar expressing pattern of ZEB1 (ZEB1) in different molecular subtypes of human and mouse breast cancers, and further show that stromal ZEB1 levels are markedly elevated upon tumour progression and correlate reversely with the breast cancer patients’ relapse-free survival rates. Here, ZEB1 is linked to neoplasm.